Developmental origins of brain tumors.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3432164)

Published in Curr Opin Neurobiol on May 05, 2012

Authors

Chong Liu1, Hui Zong

Author Affiliations

1: Institute of Molecular Biology, University of Oregon, Eugene, OR 97403, United States.

Articles cited by this

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91

Mammalian neural stem cells. Science (2000) 16.09

Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell (1999) 15.87

The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol (2002) 8.62

The transcriptional network for mesenchymal transformation of brain tumours. Nature (2009) 8.44

Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron (2011) 8.06

Cells of origin in cancer. Nature (2011) 6.85

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21

Subtypes of medulloblastoma have distinct developmental origins. Nature (2010) 5.94

Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell (2005) 5.51

Mosaic analysis with double markers in mice. Cell (2005) 5.32

Radial glia cells are candidate stem cells of ependymoma. Cancer Cell (2005) 5.21

Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11

Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell (2008) 5.06

p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature (2008) 5.00

Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell (2009) 4.82

Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell (2011) 4.78

Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell (2008) 4.68

Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron (2007) 4.47

NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development (2007) 4.21

Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci (2009) 3.72

Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature (2010) 3.70

The origins of medulloblastoma subtypes. Annu Rev Pathol (2008) 3.36

Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res (2007) 3.05

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol (2004) 2.66

Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell (2012) 2.50

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev (2011) 2.48

Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell (2009) 2.14

Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene (2009) 1.96

Non-stem cell origin for oligodendroglioma. Cancer Cell (2010) 1.95

Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol (2006) 1.92

Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS One (2011) 1.77

Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res (2003) 1.46

Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM). Proc Natl Acad Sci U S A (2007) 1.29

Extensions of MADM (mosaic analysis with double markers) in mice. PLoS One (2012) 1.06

The WHO Classification of Tumours of the Central Nervous System, 4th edition. Arch Pathol Lab Med (2008) 0.98